ELKHART, Ind. (WSBT) — Al Cover is walking and exercising again the way he was a few years ago. “I'm back to where I was before, doing hills. And in my work, my partners recognize the increase in my ...

ST. JOSEPH COUNTY, Ind. (WSBT) — The options for cardiovascular procedures have expanded over the last decade. Among options for patients with aortic stenosis - a minimally invasive procedure known as ...

CINCINNATI (WKRC) - A new trial showed a procedure that thousands need each year to keep their hearts healthy may be performed in a safer way. The alternative way may help with recovery time.

The FDA has granted pre-market approval to JenaValve’s Trilogy system, the first transcatheter aortic valve replacement (TAVR) device in the U.S. specifically indicated for severe aortic regurgitation ...

Transcatheter aortic valve replacement (TAVR) is a minimally invasive procedure that involves replacing the aortic valve in people with aortic stenosis. It has several benefits over open heart surgery ...

For all the innovation, engineering, and miniaturization that has helped to refine surgical and transcatheter aortic valve replacement over the last few decades, they still fall short of ideal. That ...

Recent developments of interest in cardiovascular medicine ...

Replacing a faulty heart valve can restore healthy circulation, but the procedure carries some risks. These include blood clots, infection, and other complications. Generally, the outlook is usually ...

A prospective, non-inferiority, randomised controlled TCW trial at 18 tertiary centres (2018-2023). Patients (n = 172) had severe aortic stenosis and complex coronary artery disease. They were ...

PARIS--(BUSINESS WIRE)--Cardiawave SA, a deeptech medical device company that has developed VALVOSOFT® a revolutionary non-invasive medical device to treat aortic stenosis, the most prevalent heart ...